Dr. Sandra Milligan, President of Aspira, aims to accelerate OVAinform and ENDOinform development to commercialization in less than two years, utilizing ARPA-H funding.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
Aspira Womens Health Inc (AWH) Q3 2024 Earnings Call Highlights: Strategic Wins Amidst Market ...
